H Abdi1, F Pourmalek1,2, M E Gleave1, A I So1, P C Black3. 1. Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Level 6, 2775 Laurel St, Vancouver, BC, V5Z 1M9, Canada. 2. School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada. 3. Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Level 6, 2775 Laurel St, Vancouver, BC, V5Z 1M9, Canada. pblack@mail.ubc.ca.
Abstract
PURPOSE: The optimal extent of pelvic lymph node dissection (PLND) during radical cystectomy (RC) in patients with urothelial carcinoma of the bladder (UCB) is the subject of ongoing debate. In this study, we compared local recurrence-free and overall survival, in addition to complication rates, after extended PLND (ePLND) compared to standard PLND (sPLND). METHODS: We reviewed the charts of 314 patients who underwent RC for UCB between 2008 and 2013. ePLND was performed in 105 patients, and 105 matched patients who underwent standard PLND (sPLND) were selected based on clinical parameters. Local recurrence-free and overall survival rates were assessed using Kaplan-Meier survival analysis, and Cox proportional hazards models were used to assess potential determinants of these outcomes. Complications were assessed at 30 and 90 days using the Clavien-Dindo reporting system. RESULTS: More lymph nodes were removed by ePLND (median 21) compared to sPLND (median 9; P < 0.001), but the rate of nodal involvement was not different. In multivariable analysis, ePLND was associated with a better local recurrence-free survival (HR = 0.63, P = 0.005), but was not an independent predictor of overall survival (HR = 1.06, P = 0.84). Estimated blood loss was greater with ePLND (1047.3 vs. 584.5 ml P < 0.001), but there was no significant difference in complications. CONCLUSIONS: Extended PLND appears to reduce the risk of local recurrence, but was not an independent predictor of overall survival in this cohort. ePLND was associated with greater blood loss compared to sPLND, but not with other perioperative complications.
PURPOSE: The optimal extent of pelvic lymph node dissection (PLND) during radical cystectomy (RC) in patients with urothelial carcinoma of the bladder (UCB) is the subject of ongoing debate. In this study, we compared local recurrence-free and overall survival, in addition to complication rates, after extended PLND (ePLND) compared to standard PLND (sPLND). METHODS: We reviewed the charts of 314 patients who underwent RC for UCB between 2008 and 2013. ePLND was performed in 105 patients, and 105 matched patients who underwent standard PLND (sPLND) were selected based on clinical parameters. Local recurrence-free and overall survival rates were assessed using Kaplan-Meier survival analysis, and Cox proportional hazards models were used to assess potential determinants of these outcomes. Complications were assessed at 30 and 90 days using the Clavien-Dindo reporting system. RESULTS: More lymph nodes were removed by ePLND (median 21) compared to sPLND (median 9; P < 0.001), but the rate of nodal involvement was not different. In multivariable analysis, ePLND was associated with a better local recurrence-free survival (HR = 0.63, P = 0.005), but was not an independent predictor of overall survival (HR = 1.06, P = 0.84). Estimated blood loss was greater with ePLND (1047.3 vs. 584.5 ml P < 0.001), but there was no significant difference in complications. CONCLUSIONS: Extended PLND appears to reduce the risk of local recurrence, but was not an independent predictor of overall survival in this cohort. ePLND was associated with greater blood loss compared to sPLND, but not with other perioperative complications.
Authors: R P Meijer; R P P Meijer; C J M Nunnink; A E Wassenaar; A Bex; H G van der Poel; B W van Rhijn; W Meinhardt; S Horenblas Journal: J Urol Date: 2011-12-15 Impact factor: 7.450
Authors: Ryan P Dorin; Siamak Daneshmand; Manuel S Eisenberg; Shahin Chandrasoma; Jie Cai; Gus Miranda; Peter W Nichols; Donald G Skinner; Eila C Skinner Journal: Eur Urol Date: 2011-07-14 Impact factor: 20.096
Authors: Jennifer Gordetsky; Emelian Scosyrev; Hani Rashid; Guan Wu; Christopher Silvers; Dragan Golijanin; Edward M Messing; Jorge L Yao Journal: Mod Pathol Date: 2011-09-09 Impact factor: 7.842
Authors: Pascal Zehnder; Urs E Studer; Eila C Skinner; Ryan P Dorin; Jie Cai; Beat Roth; Gus Miranda; Frédéric Birkhäuser; John Stein; Fiona C Burkhard; Sia Daneshmand; George N Thalmann; Inderbir S Gill; Donald G Skinner Journal: J Urol Date: 2011-08-17 Impact factor: 7.450
Authors: Michael B Farnell; Randall K Pearson; Michael G Sarr; Eugene P DiMagno; Lawrence J Burgart; Tamela R Dahl; Nathan Foster; Daniel J Sargent Journal: Surgery Date: 2005-10 Impact factor: 3.982
Authors: Girish S Kulkarni; Peter C Black; Srikala S Sridhar; Anil Kapoor; Alexandre R Zlotta; Bobby Shayegan; Ricardo A Rendon; Peter Chung; Theodorus van der Kwast; Nimira Alimohamed; Yves Fradet; Wassim Kassouf Journal: Can Urol Assoc J Date: 2019-01-31 Impact factor: 1.862
Authors: Matthias May; Hans-Martin Fritsche; Malte W Vetterlein; Patrick J Bastian; Michael Gierth; Philipp Nuhn; Atiqullah Aziz; Margit Fisch; Christian G Stief; Markus Hohenfellner; Manfred P Wirth; Vladimir Novotny; Oliver W Hakenberg; Joachim Noldus; Christian Gilfrich; Christian Bolenz; Maximilian Burger; Sabine D Brookman-May Journal: World J Urol Date: 2016-06-14 Impact factor: 4.226
Authors: M Grabbert; T Grimm; A Buchner; A Kretschmer; M Apfelbeck; G Schulz; F Jokisch; B-S Schneevoigt; C G Stief; A Karl Journal: Int Urol Nephrol Date: 2017-09-12 Impact factor: 2.370
Authors: Andrea Mari; Riccardo Campi; Riccardo Tellini; Giorgio Gandaglia; Simone Albisinni; Mohammad Abufaraj; Georgios Hatzichristodoulou; Francesco Montorsi; Roland van Velthoven; Marco Carini; Andrea Minervini; Shahrokh F Shariat Journal: World J Urol Date: 2017-11-16 Impact factor: 4.226